1. Home
  2. LPA vs CCCC Comparison

LPA vs CCCC Comparison

Compare LPA & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPA
  • CCCC
  • Stock Information
  • Founded
  • LPA 2013
  • CCCC 2015
  • Country
  • LPA United States
  • CCCC United States
  • Employees
  • LPA N/A
  • CCCC N/A
  • Industry
  • LPA
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LPA
  • CCCC Health Care
  • Exchange
  • LPA Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • LPA 196.1M
  • CCCC 175.1M
  • IPO Year
  • LPA N/A
  • CCCC 2020
  • Fundamental
  • Price
  • LPA $6.33
  • CCCC $2.60
  • Analyst Decision
  • LPA
  • CCCC Buy
  • Analyst Count
  • LPA 0
  • CCCC 2
  • Target Price
  • LPA N/A
  • CCCC $8.00
  • AVG Volume (30 Days)
  • LPA 13.0K
  • CCCC 1.7M
  • Earning Date
  • LPA 08-13-2025
  • CCCC 08-07-2025
  • Dividend Yield
  • LPA N/A
  • CCCC N/A
  • EPS Growth
  • LPA N/A
  • CCCC N/A
  • EPS
  • LPA 0.22
  • CCCC N/A
  • Revenue
  • LPA $45,924,457.00
  • CCCC $34,240,000.00
  • Revenue This Year
  • LPA N/A
  • CCCC N/A
  • Revenue Next Year
  • LPA N/A
  • CCCC N/A
  • P/E Ratio
  • LPA $29.81
  • CCCC N/A
  • Revenue Growth
  • LPA 6.18
  • CCCC 16.55
  • 52 Week Low
  • LPA $5.71
  • CCCC $1.09
  • 52 Week High
  • LPA $15.85
  • CCCC $7.22
  • Technical
  • Relative Strength Index (RSI)
  • LPA 49.93
  • CCCC 58.04
  • Support Level
  • LPA $6.21
  • CCCC $2.45
  • Resistance Level
  • LPA $6.56
  • CCCC $2.70
  • Average True Range (ATR)
  • LPA 0.34
  • CCCC 0.22
  • MACD
  • LPA 0.06
  • CCCC -0.01
  • Stochastic Oscillator
  • LPA 52.10
  • CCCC 46.24

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: